Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

41.04B

Market cap41.04B

Price-Earnings ratio

51.00

Price-Earnings ratio51.00

Dividend yield

—

Dividend yield—

Average volume

6.11M

Average volume6.11M

High today

$276.19

High today$276.19

Low today

$268.37

Low today$268.37

Open price

$274.10

Open price$274.10

Volume

253.36K

Volume253.36K

52 Week high

$280.17

52 Week high$280.17

52 Week low

$88.00

52 Week low$88.00

Stock Snapshot

Illumina(ILMN) stock is priced at $271.78, giving the company a market capitalization of 41.04B. It carries a P/E multiple of 51.00.

On 2026-10-01, Illumina(ILMN) stock moved within a range of $268.37 to $276.19. With shares now at $271.78, the stock is trading +1.3% above its intraday low and -1.6% below the session's peak.

Trading activity shows a volume of 253.36K, compared to an average daily volume of 6.11M.

Over the past 52 weeks, Illumina(ILMN) stock has traded between a high of $280.17 and a low of $88.00.

ILMN News

TipRanks 2h

Illumina price target raised to $305 from $226 at Guggenheim

Guggenheim analyst Subbu Nambi raised the firm’s price target on Illumina (ILMN) to $305 from $226 and keeps a Buy rating on the shares. The firm adjusted its m...

Nasdaq 2d

Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?

Illumina (NASDAQ: ILMN) is building a deeper AI strategy around the biological data created by its sequencing technology. The Billion Cell Atlas, expanding drug...

Zacks 2d

REGN or ILMN: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Regeneron (REGN Quick QuoteREGN - Free Report) and Illumina (ILM...

Analyst ratings

46%

of 24 ratings

Buy

45.8%

Hold

37.5%

Sell

16.7%

More ILMN News

Simply Wall St 2d

Illumina, What Is Drawing Fresh Attention Now?

Advertisement Illumina options activity and index change catch investor attention Illumina (ILMN) has moved into focus after two separate signals. The stock w...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.